AU2015904895A0 - Compounds for medicinal applications - Google Patents

Compounds for medicinal applications

Info

Publication number
AU2015904895A0
AU2015904895A0 AU2015904895A AU2015904895A AU2015904895A0 AU 2015904895 A0 AU2015904895 A0 AU 2015904895A0 AU 2015904895 A AU2015904895 A AU 2015904895A AU 2015904895 A AU2015904895 A AU 2015904895A AU 2015904895 A0 AU2015904895 A0 AU 2015904895A0
Authority
AU
Australia
Prior art keywords
compounds
medicinal applications
medicinal
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015904895A
Inventor
Peter James Jenkins
Betty Jin
Paul Arthur Jones
Ee-Ling SEAH
Henry Kenneth WINDLE
Wen Yang Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian Biomedical Co Pty Ltd
Original Assignee
Australian Biomedical Co Pty Ltd
Filing date
Publication date
Application filed by Australian Biomedical Co Pty Ltd filed Critical Australian Biomedical Co Pty Ltd
Publication of AU2015904895A0 publication Critical patent/AU2015904895A0/en
Priority to BR112018010027A priority Critical patent/BR112018010027A2/en
Priority to PCT/AU2016/051100 priority patent/WO2017083914A1/en
Priority to MYPI2018701859A priority patent/MY195168A/en
Priority to KR1020187017047A priority patent/KR20180083402A/en
Priority to CA3005774A priority patent/CA3005774C/en
Priority to UAA201806293A priority patent/UA126654C2/en
Priority to NZ742593A priority patent/NZ742593B2/en
Priority to CN201680075964.XA priority patent/CN108473483B/en
Priority to EA201891072A priority patent/EA033921B9/en
Priority to SG11201803962WA priority patent/SG11201803962WA/en
Priority to EP16865298.0A priority patent/EP3377487B1/en
Priority to AU2016356726A priority patent/AU2016356726C1/en
Priority to ES16865298T priority patent/ES2911027T3/en
Priority to JP2018525746A priority patent/JP7034913B2/en
Priority to MX2018005999A priority patent/MX2018005999A/en
Priority to TW105137966A priority patent/TWI742015B/en
Priority to ZA2018/03214A priority patent/ZA201803214B/en
Priority to IL259425A priority patent/IL259425B/en
Priority to PH12018501076A priority patent/PH12018501076A1/en
Priority to US15/984,029 priority patent/US11007274B2/en
Abandoned legal-status Critical Current

Links

AU2015904895A 2015-11-20 2015-11-20 Compounds for medicinal applications Abandoned AU2015904895A0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
MX2018005999A MX2018005999A (en) 2015-11-20 2016-11-16 Compounds for medicinal applications.
EA201891072A EA033921B9 (en) 2015-11-20 2016-11-16 Sialic acid derivatives and use thereof in treating influenza viral infections
AU2016356726A AU2016356726C1 (en) 2015-11-20 2016-11-16 Compounds for medicinal applications
MYPI2018701859A MY195168A (en) 2015-11-20 2016-11-16 Compounds for Medicinal Applications
KR1020187017047A KR20180083402A (en) 2015-11-20 2016-11-16 Compounds for medical use
CA3005774A CA3005774C (en) 2015-11-20 2016-11-16 Compounds and methods for the treatment and/or prevention of influenza infection
UAA201806293A UA126654C2 (en) 2015-11-20 2016-11-16 Compounds for medicinal applications
NZ742593A NZ742593B2 (en) 2016-11-16 Compounds for medicinal applications
CN201680075964.XA CN108473483B (en) 2015-11-20 2016-11-16 Compounds for medical use
BR112018010027A BR112018010027A2 (en) 2015-11-20 2016-11-16 compound, pharmaceutical composition, method for treating or preventing viral influenza infection, and use of a compound.
SG11201803962WA SG11201803962WA (en) 2015-11-20 2016-11-16 Compounds for medicinal applications
EP16865298.0A EP3377487B1 (en) 2015-11-20 2016-11-16 Compounds for medicinal applications
PCT/AU2016/051100 WO2017083914A1 (en) 2015-11-20 2016-11-16 Compounds for medicinal applications
ES16865298T ES2911027T3 (en) 2015-11-20 2016-11-16 Compounds for medicinal applications
JP2018525746A JP7034913B2 (en) 2015-11-20 2016-11-16 Medicinal compound
TW105137966A TWI742015B (en) 2015-11-20 2016-11-18 Compounds for medicinal applications
ZA2018/03214A ZA201803214B (en) 2015-11-20 2018-05-15 Compounds for medicinal applications
IL259425A IL259425B (en) 2015-11-20 2018-05-16 Compounds for medicinal applications
PH12018501076A PH12018501076A1 (en) 2015-11-20 2018-05-18 Compounds for medicinal applications
US15/984,029 US11007274B2 (en) 2015-11-20 2018-05-18 Compounds for medicinal applications

Publications (1)

Publication Number Publication Date
AU2015904895A0 true AU2015904895A0 (en) 2015-12-10

Family

ID=

Similar Documents

Publication Publication Date Title
EP3319606A4 (en) Pharmaceutical compound
EP3286169A4 (en) Novel compounds
IL258213A (en) Pharmaceutical compounds
GB201612092D0 (en) Pharmaceutical compounds
EP3325449A4 (en) Compounds
EP3104860A4 (en) Pharmaceutical compounds
GB201506658D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
GB201504675D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
GB201519352D0 (en) Pharmaceutical compounds
GB201612095D0 (en) Pharmaceutical compounds
EP3310439A4 (en) Pharmaceutical compositions for anesthesiological applications
EP3349750A4 (en) Pharmaceutical compound
EP3464336A4 (en) Compounds
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
EP3278801A4 (en) Medicinal composition containing mirabegron
EP3246047A4 (en) Combination drug
EP3332819A4 (en) Syringe
EP3402829A4 (en) Silicone-compatible compounds
EP3259254A4 (en) Therapeutic compounds
EP3281641A4 (en) Medicine
EP3255044A4 (en) Diaza-benzofluoranthrene compounds
EP3250551A4 (en) Anti-cancer compounds